Targeted Assessment of the
EGFR
lung cancer
next generation sequencing
targeted sequencing
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
13 Apr 2020
13 Apr 2020
Historique:
received:
09
02
2020
revised:
11
03
2020
accepted:
01
04
2020
entrez:
17
4
2020
pubmed:
17
4
2020
medline:
17
4
2020
Statut:
epublish
Résumé
Assessment of actionable A total of 901 biopsies from NSLC with more than 10% of tumor cells were prospectively and consecutively evaluated for Results were obtained from 889/901 (97%) biopsies with detection of Rapid and targeted assessment of
Sections du résumé
BACKGROUND
BACKGROUND
Assessment of actionable
METHODS
METHODS
A total of 901 biopsies from NSLC with more than 10% of tumor cells were prospectively and consecutively evaluated for
RESULTS
RESULTS
Results were obtained from 889/901 (97%) biopsies with detection of
CONCLUSIONS
CONCLUSIONS
Rapid and targeted assessment of
Identifiants
pubmed: 32294880
pii: cancers12040955
doi: 10.3390/cancers12040955
pmc: PMC7225982
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Value Health. 2018 Nov;21(11):1278-1285
pubmed: 30442274
J Clin Oncol. 2015 Jun 10;33(17):1958-65
pubmed: 25897154
Clin Lung Cancer. 2020 Jan;21(1):56-65.e8
pubmed: 31519454
Methods Mol Biol. 2019;2054:147-155
pubmed: 31482454
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv192-iv237
pubmed: 30285222
PLoS One. 2017 Aug 10;12(8):e0183023
pubmed: 28797130
Eur J Cancer. 2019 Feb;108:88-96
pubmed: 30648633
CA Cancer J Clin. 2019 Jul;69(4):305-343
pubmed: 31116423
J Clin Pathol. 2017 Apr;70(4):295-300
pubmed: 27543600
Oncotarget. 2017 Oct 4;8(61):103055-103062
pubmed: 29262544
J Clin Oncol. 2018 Mar 20;36(9):911-919
pubmed: 29401004
J Thorac Oncol. 2020 May;15(5):803-815
pubmed: 31931137
Arch Pathol Lab Med. 2019 May;143(5):628-633
pubmed: 30576239
Ann Oncol. 2019 May 1;30(5):757-765
pubmed: 30865223
Clin Lung Cancer. 2019 Jul;20(4):231-236
pubmed: 30797721
J Mol Diagn. 2019 Nov;21(6):1010-1024
pubmed: 31445213
Lung Cancer. 2017 Jul;109:137-144
pubmed: 28577943
Cancers (Basel). 2018 Mar 21;10(4):
pubmed: 29561830
J Clin Pathol. 2017 Jun;70(6):544-549
pubmed: 28153953
Signal Transduct Target Ther. 2019 Mar 8;4:5
pubmed: 30854234
Clin Lung Cancer. 2016 Nov;17(6):483-492
pubmed: 27381270
Nat Rev Cancer. 2019 Sep;19(9):495-509
pubmed: 31406302
J Mol Diagn. 2019 Sep;21(5):862-872
pubmed: 31443844
Pathol Res Pract. 2020 Jan;216(1):152773
pubmed: 31836323
J Thorac Oncol. 2017 Apr;12(4):612-623
pubmed: 28017789
Medicine (Baltimore). 2018 Mar;97(9):e0006
pubmed: 29489642
J Thorac Oncol. 2019 Jul;14(7):1204-1212
pubmed: 30999109
Ann Oncol. 2013 Mar;24(3):742-8
pubmed: 23131393
Ann Oncol. 2012 Nov;23(11):2907-13
pubmed: 22735679
J Clin Pathol. 2020 Jan;73(1):35-41
pubmed: 31296605
Clin Cancer Res. 2019 Feb 1;25(3):899-900
pubmed: 30190372
Oncotarget. 2016 Nov 29;7(48):78985-78993
pubmed: 27738317
Cancer Treat Commun. 2016;9:41-43
pubmed: 28111612
JCO Precis Oncol. 2018;2018:
pubmed: 30370396
Clin Cancer Res. 2019 Feb 1;25(3):1063-1069
pubmed: 30045933